![Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden - IHE Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden - IHE](http://ihe.se/wp-content/uploads/2020/09/Diabetes.jpg)
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden - IHE
![Microvascular and Macrovascular Complications in Young-onset Type 2 Diabetes in a Tertiary Health Institution in Malaysia in Comparison with Type 1 Diabetes Patients | Journal of the ASEAN Federation of Endocrine Societies Microvascular and Macrovascular Complications in Young-onset Type 2 Diabetes in a Tertiary Health Institution in Malaysia in Comparison with Type 1 Diabetes Patients | Journal of the ASEAN Federation of Endocrine Societies](https://asean-endocrinejournal.org/public/site/images/admin/va-26-lay.jpg)
Microvascular and Macrovascular Complications in Young-onset Type 2 Diabetes in a Tertiary Health Institution in Malaysia in Comparison with Type 1 Diabetes Patients | Journal of the ASEAN Federation of Endocrine Societies
![Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms - ScienceDirect Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661817315190-gr1.jpg)
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms - ScienceDirect
![Frontiers | Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes Frontiers | Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes](https://www.frontiersin.org/files/MyHome%20Article%20Library/387172/387172_Thumb_400.jpg)
Frontiers | Therapeutic Options Targeting Oxidative Stress, Mitochondrial Dysfunction and Inflammation to Hinder the Progression of Vascular Complications of Diabetes
![Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-018-4729-5/MediaObjects/125_2018_4729_Fig1_HTML.png)
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink
![Pharmaceuticals | Free Full-Text | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus Pharmaceuticals | Free Full-Text | Pharmaceutical Drugs and Natural Therapeutic Products for the Treatment of Type 2 Diabetes Mellitus](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00806/article_deploy/html/images/pharmaceuticals-14-00806-g001-550.jpg)